154 related articles for article (PubMed ID: 38675374)
1. Optimizing Paclitaxel Oral Absorption and Bioavailability: TPGS Co-Coating via Supercritical Anti-Solvent Fluidized Bed Technology.
Zhong Z; Lan Y; Chen J; Ping L; Li X; Wang Q; Zhuang X; Qiu Z; Yuan T; Guo Q; Xi L; Li Q; Luo D
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675374
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the supercritical fluidized bed process for sirolimus coating and drug release.
Chen T; Liu L; Zhang L; Lu T; Matos RL; Jiang C; Lin Y; Yuan T; Ma Z; He H; Zhuang X; Li Q
Int J Pharm; 2020 Nov; 589():119809. PubMed ID: 32896606
[TBL] [Abstract][Full Text] [Related]
3. Supercritical fluid coating of flavonoids on excipients enhances drug release and antioxidant activity.
He H; Huang Y; Zhang X; Ouyang Y; Pan P; Lan Y; Zhong Z; Ping L; Lu T; Chen Z; Xing L; Li Q; Qiu Z
Int J Pharm; 2023 Feb; 632():122593. PubMed ID: 36626970
[TBL] [Abstract][Full Text] [Related]
4. Characterization of excipients to improve pharmaceutical properties of sirolimus in the supercritical anti-solvent fluidized process.
Chen T; Ma Z; Qiu Z; Zhong Z; Xing L; Guo Q; Luo D; Weng Z; Ge F; Huang Y; Zhang X; He H; Zhuang X; Li Q; Yuan T
Int J Pharm; 2022 Jan; 611():121240. PubMed ID: 34780928
[TBL] [Abstract][Full Text] [Related]
5. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
[TBL] [Abstract][Full Text] [Related]
6. Supercritical antisolvent-fluidized bed for the preparation of dry powder inhaler for pulmonary delivery of nanomedicine.
Ma Z; Zhang X; Ping L; Zhong Z; Zhang X; Zhuang X; Wang G; Guo Q; Zhan S; Qiu Z; Zhao Z; Li Q; Luo D
Int J Pharm; 2023 Dec; 648():123580. PubMed ID: 37944677
[TBL] [Abstract][Full Text] [Related]
7. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.
Varma MV; Panchagnula R
Eur J Pharm Sci; 2005; 25(4-5):445-53. PubMed ID: 15890503
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effect of folated pluronic F87-PLA/TPGS mixed micelles on targeted delivery of paclitaxel.
Xiong XY; Pan X; Tao L; Cheng F; Li ZL; Gong YC; Li YP
Int J Biol Macromol; 2017 Oct; 103():1011-1018. PubMed ID: 28552723
[TBL] [Abstract][Full Text] [Related]
9. Surface modification of paclitaxel-loaded liposomes using d-α-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells.
Han SM; Baek JS; Kim MS; Hwang SJ; Cho CW
Chem Phys Lipids; 2018 Jul; 213():39-47. PubMed ID: 29550143
[TBL] [Abstract][Full Text] [Related]
10. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
11. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process.
Ahn JB; Kim DH; Lee SE; Pyo YC; Park JS
Int J Pharm; 2019 Jun; 564():263-272. PubMed ID: 31015003
[TBL] [Abstract][Full Text] [Related]
13. Formulation, characterization, and in vivo evaluation of celecoxib-PVP solid dispersion nanoparticles using supercritical antisolvent process.
Ha ES; Choo GH; Baek IH; Kim MS
Molecules; 2014 Dec; 19(12):20325-39. PubMed ID: 25486246
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
Kim DS; Kim DW; Kim KS; Choi JS; Seo YG; Youn YS; Oh KT; Yong CS; Kim JO; Jin SG; Choi HG
Colloids Surf B Biointerfaces; 2016 Nov; 147():250-257. PubMed ID: 27518457
[TBL] [Abstract][Full Text] [Related]
15. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
Huang G; Zang B; Wang X; Liu G; Zhao J
Acta Biochim Biophys Sin (Shanghai); 2015 Dec; 47(12):981-7. PubMed ID: 26525950
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
17. Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as Curcumin Nanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model.
Rachmawati H; Pradana AT; Safitri D; Adnyana IK
Pharmaceutics; 2017 Jul; 9(3):. PubMed ID: 28754010
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
Pooja D; Kulhari H; Singh MK; Mukherjee S; Rachamalla SS; Sistla R
Colloids Surf B Biointerfaces; 2014 Sep; 121():461-8. PubMed ID: 25063311
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
